DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20220015
Published: 2022-01-29

Evaluation of the role of fundus fluorescein angiography and spectral domain-optical coherence tomography in choroidal neo-vascularization: a hospital-based study

Amit Singh, Reyaz Ahmed Untoo, Ourfa Ashraf Wani, Wasim Rashid

Abstract


Background: The study was conducted to evaluate the role of fundus fluorescein angiography (FFA) and spectral domain-optical coherence tomography (SD-OCT) in choroidal neo-vascularisation (CNV).

Methods: This was a hospital based prospective study carried out in the post-graduate department of ophthalmology, SKIMS medical college, Bemina, Srinagar, Jammu and Kashmir. All patients diagnosed with CNV fulfilling the criteria during the study period w.e.f. October 2018 to March 2020 were enrolled. Visual acuity and pinhole test using Snellen’s chart for literate and E chart for illiterate patient, slit lamp biomicroscope for anterior segment examination, ophthalmoscopy, including stereoscopic examination of the posterior pole, 90D examination of the fundus, Intra-ocular pressure measurement, FFA and SD-OCT was done in these patients.

Results: Diagnostic accuracy of OCT was observed with a sensitivity 79.1% (95% confidence interval (CI): 67.3-90.7), specificity 84.3% (95% CI: 74.5-92.9), positive and negative predictive values 78.7% and 85.4%, respectively, (95% CI: 65.5-95.6) and (74.8-93.4) and diagnostic accuracy of FFA was observed with a sensitivity 81.4% (95% confidence interval (CI): 70.6-93.5), specificity 82.31% (95% CI: 71.9-89.3), positive and negative predictive values 79.9% and 83.7%, respectively, (95% CI: 68.8-92.9) and (70.3-91.2).

Conclusions: FFA is the gold standard procedure for screening ARMD and detection of dry ARMD, but OCT is more specific diagnostic tool in detecting early subretinal neovascular membrane and also to assess the extent, location and activity of the neovascular membranes. This study concludes that SDOCT is highly sensitive for identifying AMD, CNV, and CNV activity and due to its non-invasive nature with no adverse effects and less time consuming can be used as 1st line of diagnostic modality and FFA be reserved for cases where SD-OCT is not helpful.


Keywords


FFA, SD-OCT, CNV

Full Text:

PDF

References


Tso MO. Pathogenetic factors of aging macular degeneration. Ophthalmology. 1985;92:628-35.

Handelman GJ, Dratz EA. The role of antioxidants in the retina and retinal pigment epithelium and the nature of prooxidant-induced damage. Adv Free Radic Biol Med. 1980;2: l-9.

Bray TM, Bettger WJ. The physiological role of zinc as an antioxidant. Free Radic Biol Med. 1990;8:281-91.

Krinsky NI. Antioxidant functions of carotenoids. Free Radic Biol Med. 1989;7:617-35.

Hyman LG, Lillienfeld AM, Ferris III FL, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983;118:213-27.

Chandra SR, Gragoudas ES, Friedman E, van Buskirk CM, Klien ML. Natural history of disciform degeneration of the macula. Am J Ophthalmol 1974;78:579-82.

Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol. 1977;61:141-7.

Strahlman ER, Fine SL, Hills A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 1983;101:1191-93.

Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol. 1993;111:1189-99.

Reddy U, Krzystolik M. Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2006;1:CD005138.

Macular Photocoagulation Study Group. Sub foveal neovascular lesions in age-related macular degeneration. Arch Ophthalmol. 1991;109:1242-57.

Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol. 1999;117:1329-45.

Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of sub foveal choroidal neo vascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol. 2001;119:198-207.

Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of sub foveal choroidal neo vascularization in pathological myopia with verteporfin: one-year results of a randomized clinical trial-VIP Report Number 1. Ophthalmology. 2001;108:841-52.

Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of sub foveal choroidal neo vascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-VIP Report Number 2. Am J Ophthalmology. 2001;131:541-60.

Hee MR, Baumal CR, Puliafito CA. Optical coherence tomography of age-related macular degeneration and choroidal neovascularisation. Ophthalmology. 1996;103:1260-70.

Rogers AH, Martidis A, Greenberg PB. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularisation. Am J Ophthalmol. 2002;134:566-76.

Hee MR, Izatt JA, Swanson EA. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-32.

Schuman JS, Puliafito CA, Fujimoto JG. Age-related macular degeneration. in optical coherence tomography of ocular diseases. 2nd ed. New York: Slack Incorporated. 2004;243-344.

El-Sadany AEI, Marey HM, El-Sawy MF, Fadel AZ. Correlation of optical coherence tomography and fluorescein angiography imaging in neovascular age-related macular degeneration. Menoufia Med J. 2015;28:902-7.

Chhablani J, Deepa MJ, Tyagi M, Narayanan R, Kozak I. Fluorescein angiography and optical coherence tomography in myopic choroidal neovascularization. Eye (London). 2015;29(4):519-24.

Bressler NM, Bressler SB, West SK. The grading and prevalence of macular degeneration in Chesapeake Bay Watermen. Arch Ophthalmol. 1989;107:847-52.

Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-43.

Balasubramaniam P, Elumalai S. Comparison of fundus fluorescein angiography and optical coherence tomography in age-related macular degeneration. JEBMH 2016; 3(84): 4570-76.

Ryan SJ, Schachat AP, Wilkinson CP. Age-related macular degeneration. In: Text book of retina. 5th edn. Vol 2. Elsevier. 2005;907-1012.

Qureshi T, MajidNazir, Abdulla N. Profile of age-related macular degeneration in a Kashmiri population- a hospital-based study in tertiary care hospital in Kashmir, India. GJMEDPH. 2013;2(2):1-7.

Sandhu SS, Talks SJ. Correlation of optical coherence tomography with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Brit J Ophthalmol. 2005;89(9):967-70.

Mathew R, Pefkianaki M, Kopsachilis N, Brar M, Richardson M, Sivaprasad S. Correlation of fundus fluorescein angiography and spectral-domain optical coherence tomography in identification of membrane subtypes in neovascular age-related macular degeneration. Ophthalmologica. 2014;231:153-9.

Nikolopoulou E, Lorusso M, Micelli Ferrari L, Cicinelli MV, Bandello F, Querques G et al. Optical coherence tomography angiography versus dye angiography in age-related macular degeneration: sensitivity and specificity analysis. BioMed Res Int. 2018;2018:7.

Shaimov TB, Panova IE, Shaimov RB, Shaimova VA, Shaimova TA, Fomin AV. Optical coherence tomography angiography in the diagnosis of neovascular age-related macular degeneration. Vestn Oftalmol. 2015;131:4-12.